Atrion (ATRI) has a profit margin of 6.91%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2024
Trailing 12 months ending Jun 2024
Atrion (ATRI) currently reports a profit margin of 6.91% as of June 2024. That compares with 15.88% in the prior-year period — down 56.5% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Atrion's profit margin history and peer comparisons.
Atrion's profit margin decreased from 15.88% to 6.91% — a 56.5% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Atrion's profit margin of 6.91% is lower than the Healthcare sector average of 13.89%. That is roughly 50.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Atrion's current 6.91% should be judged against Healthcare norms (sector average: 13.89%) and against ATRI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 6.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Atrion, and consider following ATRI for alerts when major investors trade the stock.